Research Article

Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes

Table 2

Univariate Cox proportional hazard regression analysis results

VariablesHR95% CI value

Age, y1.061.011.190.025
Duration of diabetes, y1.081.011.140.017
Disease severity
Nonsevere1
Severe1.160.225.980.86
Critical7.051.5232.70.013
Cardiovascular and cerebrovascular diseases5.031.8813.430.0013

Neutrophil count (109/L)
<401.330.266.870.73
40–751
>754.211.3712.940.012

Aspartate aminotransferase, U/L
13–351
>357.92.723.130.0008

Serum amyloid A (SAA), mg/L1.011.0061.02<0.0001
Blood glucose, mmol/L1.151.051.260.0022
Diabetes treatment
Oral medication plus insulin0.2020.0450.910.037
Oral medication only0.0630.0140.280.0003
Insulin only1

Antibiotics
Ganciclovir5.271.223.210.028
Corticosteroid/glucocorticoid10.312.3245.760.0022